Related Experiment Video
Updated: Jun 5, 2026

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
Published on: April 19, 2011
Adenosine receptors and cardiovascular function
1Department of Medicine, Cardiology Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Abstract:
Adenosine exerts pronounced cardiac and vascular effects. Distinct receptors, present on the endothelium and vascular and cardiac myocytes, mediate the various cardiovascular effects of adenosine. The A(1) and the A(2) subtypes of adenosine receptor are coupled to different G proteins, second messengers, and physiologic responses. Recent cloning of the two subtypes of adenosine receptor should enhance our understanding of the structure, function, and regulation of these receptors and should facilitate discovery of new subtypes that may be expressed in a tissue-specific manner. These molecular advances should also provide insights into the mechanism of the cardiovascular action of adenosine, which is gaining greater clinical usefulness.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers

